Anesth Analg 2002;95:1763-1766
© 2002 International Anesthesia Research Society
REGIONAL ANESTHESIA
Prophylactic Ondansetron Reduces the Incidence of Intrathecal Fentanyl-Induced Pruritus
Yavuz Gürkan, and
Kamil Toker
Kocaeli University School of Medicine, Department of Anesthesiology and Reanimation, Kocaeli, Turkey
Address correspondence and reprint requests to Dr. Yavuz Gürkan, Kalamis, Erguvan Sok. Kucukgul Apt. No. 17/6, Kadikoy, Istanbul, 81030, Turkey. Address e-mail to yavuzg{at}superonline.com
We investigated the effectiveness of prophylactic IV ondansetron in preventing intrathecal fentanyl-induced pruritus. One-hundred-fifty ASA status III patients undergoing spinal anesthesia with 710 mg of hyperbaric bupivacaine and 25 µg of fentanyl were randomized to receive ondansetron 8 mg IV or normal saline IV before the commencement of spinal anesthesia. Evaluations were performed every 15 min in the first hour after the injection of study drugs and at 1, 2, 3, 4, 5, and 6 h after the administration of the study drug. Statistical analysis was performed by using 2 tests and Students t-test, as appropriate. The incidence of pruritus was significantly more frequent in the placebo group compared with the ondansetron group (68% versus 39%) (P = 0.001). Time to pruritus was similar in both groups (placebo group, 55 ± 32 min versus ondansetron group, 50 ± 31 min). Duration of pruritus was also similar in both groups (placebo group, 98 ± 60 min versus ondansetron group, 103 ± 58 min). Ondansetron prophylaxis significantly reduced the incidence of intrathecal fentanyl-induced pruritus in patients undergoing surgery under bupivacaine spinal anesthesia.
IMPLICATIONS: Pruritus is a commonly reported side effect after intrathecal fentanyl administration during spinal anesthesia. This study was performed in a prospective, randomized, double-blinded, placebo-controlled manner to investigate the efficacy of prophylactic IV ondansetron in the prevention of pruritus after intrathecal fentanyl administration during spinal anesthesia. The incidence of pruritus was significantly more frequent in the placebo group compared with the ondansetron group (68% versus 39%) (P = 0.001).
This article has been cited by other articles:

|
 |

|
 |
 
M. J. Sheen, S.-T. Ho, C.-H. Lee, Y.-C. Tsung, F.-L. Chang, and S.-T. Huang
Prophylactic mirtazapine reduces intrathecal morphine-induced pruritus
Br. J. Anaesth.,
November 1, 2008;
101(5):
711 - 715.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-P. Bonnet, E. Marret, J. Josserand, and F. J. Mercier
Effect of prophylactic 5-HT3 receptor antagonists on pruritus induced by neuraxial opioids: a quantitative systematic review
Br. J. Anaesth.,
September 1, 2008;
101(3):
311 - 319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Sheen, S.-T. Ho, C.-H. Lee, Y.-C. Tsung, and F.-L. Chang
Preoperative Gabapentin Prevents Intrathecal Morphine-Induced Pruritus After Orthopedic Surgery
Anesth. Analg.,
June 1, 2008;
106(6):
1868 - 1872.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Pirat, S. F. Tuncay, A. Torgay, S. Candan, and G. Arslan
Ondansetron, Orally Disintegrating Tablets Versus Intravenous Injection for Prevention of Intrathecal Morphine-Induced Nausea, Vomiting, and Pruritus in Young Males
Anesth. Analg.,
November 1, 2005;
101(5):
1330 - 1336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Nojima, C. T. Simons, J. M. Cuellar, M. I. Carstens, J. A. Moore, and E. Carstens
Opioid Modulation of Scratching and Spinal c-fos Expression Evoked by Intradermal Serotonin
J. Neurosci.,
November 26, 2003;
23(34):
10784 - 10790.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|